8th January 2025
8th January 2025
MPM BioImpact Announces Promotion of Rami Rahal, Ph.D., to Partner
7th January 2025
Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)
3rd December 2024
Watch: MPM BioImpact Founder and Managing Partner Ansbert Gadicke on the BioVenture Voices Podcast with Chris Garabedian
18th November 2024
MPM BioImpact-Founded Company, Syndax, Announces FDA Approval of Revuforj® (revumenib)
14th November 2024
Dr. Michael Ehlers Joins MPM BioImpact as Entrepreneur Partner – Endpoints News
14th November 2024
Michael Ehlers, M.D., Ph.D., Experienced R&D Leader and Accomplished Biotechnology Executive, Appointed as MPM BioImpact Entrepreneur Partner
7th May 2024
Ivan Cheung, CEO of NextPoint Therapeutics, Named to TIME Magazine’s Top 100 Most Influential People in Global Health
11th April 2024
MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner
26th February 2024